nimustine has been researched along with Glioblastoma with Sarcomatous Component in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kikuchi, T; Kumabe, T; Sonoda, Y; Sugiyama, S; Tominaga, T; Yamashita, Y | 1 |
| Kumabe, T; Nakamura, T; Saito, R; Sonoda, Y; Sugiyama, S; Tominaga, T | 1 |
| Kikuchi, T; Kumabe, T; Saito, R; Sugiyama, S; Tominaga, T; Yamashita, Y | 1 |
| Chen, KT; Hau, DM; Pan, HC; Wong, RW; You, JS | 1 |
4 other study(ies) available for nimustine and Glioblastoma with Sarcomatous Component
| Article | Year |
|---|---|
Enhanced antitumor effect of combined-modality treatment using convection-enhanced delivery of hydrophilic nitrosourea with irradiation or systemic administration of temozolomide in intracranial brain tumor xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line, Tumor; Combined Modality Therapy; Convection; Cranial Irradiation; Dacarbazine; Disease Models, Animal; Drug Delivery Systems; Gliosarcoma; Injections, Intraperitoneal; Male; Nimustine; Rats; Rats, Inbred F344; Survival Analysis; Survival Rate; Temozolomide; Treatment Outcome; Xenograft Model Antitumor Assays | 2008 |
Local convection-enhanced delivery of chemotherapeutic agent transiently opens blood-brain barrier and improves efficacy of systemic chemotherapy in intracranial xenograft tumor model.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Convection; Doxorubicin; Drug Delivery Systems; Gliosarcoma; Kaplan-Meier Estimate; Male; Nimustine; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Treatment Outcome; Xenograft Model Antitumor Assays | 2011 |
Safety and efficacy of convection-enhanced delivery of ACNU, a hydrophilic nitrosourea, in intracranial brain tumor models.
Topics: Animals; Antineoplastic Agents; Brain; Brain Neoplasms; Cell Line, Tumor; Chemotherapy, Cancer, Regional Perfusion; Convection; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Delivery Systems; Gliosarcoma; Humans; Male; Maximum Tolerated Dose; Nimustine; Random Allocation; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Survival Analysis; Tissue Distribution; Treatment Outcome; Xenograft Model Antitumor Assays | 2007 |
Therapeutic effects of photosensitizers in combination with laser and ACNU on an in vivo or in vitro model of cerebral glioma.
Topics: Animals; Brain Neoplasms; DNA, Neoplasm; Gliosarcoma; Hematoporphyrin Derivative; Humans; Laser Therapy; Male; Neoplasm Transplantation; Nimustine; Photochemotherapy; Rats; Rats, Sprague-Dawley; RNA, Neoplasm; Tumor Cells, Cultured | 1995 |